Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
Neurobiology of Disease|June 27, 2022
In utero alcohol exposure impairs vessel-associated positioning and differentiation of oligodendrocytes in the developing neocortexM Brosolo, M Lecointre, A Laquerrière, et al.
Cell Death & Disease|July 4, 2014
Ketamine alters cortical integration of GABAergic interneurons and induces long-term sex-dependent impairments in transgenic Gad67-GFP miceC Aligny, C Roux, N Dourmap, et al.
Gynecologie, Obstetrique & Fertilite|March 14, 2008
[Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial]S Marret, L Marpeau, C Follet-Bouhamed, et al.
Gynecologie, Obstetrique & Fertilite|April 18, 2008
[Vaccine prevention in perinatal health care: parents, children and professionals]D Pinquier, A Gagneur, C Gras-Le Guen, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 20, 2009
[Special outpatient services at 5 and 8 years in very-preterm children in the EPIPAGE study]S Marret, P-Y Ancel, L Marchand, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 18, 2007
Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and 5-year neurodevelopmental outcomes of very preterm infants: the EPIPAGE cohort studyL Foix-L'Hélias, S Marret, P-Y Ancel, et al.
Nature Communications|October 13, 2022
[2]-Ladderanes as isosteres for meta-substituted aromatic rings and rigidified cyclohexanesRachel C Epplin, Shashwati Paul, Loïc Herter, et al.
The Journal of Pediatrics|October 23, 2003
White matter damage and intraventricular hemorrhage in very preterm infants: the EPIPAGE studyBéatrice Larroque, S Marret, Pierre-Yves Ancel, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 19, 2011
Height at 2 and 5 years of age in children born very preterm: the EPIPAGE studyV Pierrat, L Marchand-Martin, I Guemas, et al.
Revue Neurologique|April 4, 2016
Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic diseaseA Béhin, C Acquaviva-Bourdain, S Souvannanorath, et al.
Pageof 21